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Letters to the Editorseen in a subgroup of patients with ag-
gressive coronary atherosclerosis.
Conversely, the pathophysiologic re-
sponse5 to the presence of an intravas-
cular foreign body (stent) may also
adversely affect the fate of the conduits
used to graft stented coronary arteries.
Stenting can cause prolonged endothe-
lial dysfunction, as well as an acute
and chronic inflammatory reaction,
even during the late period, with in-
volvement of the distal coronary artery
and surrounding myocardium.5 This
may adversely affect anastomosis sites
in patients who subsequently undergo
coronary artery bypass grafting.
A vexed question is whether the
poor fate of venous conduits used to
bypass coronary arteries with in-stent
restenosis is due to aggressive athero-
sclerosis or to an inflammatory reac-
tion involving downstream coronary
artery beds. Although we do not
know the distribution of occluded con-
duits with respect to stent locations,
we cannot definitively point out the
influences on graft patency. We there-
fore do not support inclusion of these
data in meta-analyses.
Dusko Nezic, MD, PhD, FETCS
Aleksandar Knezevic, MD, BcS
Petar Vukovic, MD, BcS
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We thank Nezic and colleagues for
their interest in our recent article.1 We
regret to point out, however, that
Nezic and colleagues misrepresent
data reported by Gaudino and associ-
ates.2 In fact, 2 different analyses
were reported in that study. First, Gau-
dino and associates2 reported an an-
giographic comparison of radial
artery (RA) and saphenous vein graft
(SVG) conduits randomly assigned
to target obtuse marginal coronary ar-
teries (OMs) with previous stenting
(study group) versus OMs without
previous (control group). The results
of this comparison were shown in
Gaudino and associates’ Table 3,2
which compared 20 RA conduits
versus 20 SVG conduits from the
study group and 20 RA conduits ver-
sus 20 SVG conduits from the control
group. In addition, they reported an-
giographic results of other conduits
not randomly assigned to complete re-
vascularization in both the study and
control groups (see Gaudino and asso-
ciates’ Table 22).
For the purpose of ourmeta-analysis
of randomized, controlled trials, we in-
cluded only conduits randomly as-
signed to target OMs. Therefore, in
our study the Gaudino I study included
RA versus SVG conduits randomly
grafted to previously stented OMs,
and the Gaudino II study included
RA versus SVG conduits grafted to un-
stented OMs. The risk that intrastent
restenosis would influence the results
was exactly the same for all RA and
SVG conduits used in the first cohort
of patients (Gaudino I). Nezic and
colleagues picked up data referring
to conduits not randomly assigned to
complete revascularization (see Gau-
dino and associates’ Table 2), thus
completely misrepresenting the inclu-
sion criteria adopted in our meta-
analysis of randomized, controlled
trials.
Umberto Benedetto, MD
Emiliano Angeloni, MDof Thoracic and Cardiovascular SurgerRiccardo Sinatra, MD
Cardiac Surgery Department
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To the Editor:
The meta-analytical review by
Benedetto and colleagues1 comparing
failure rates of radial artery (RA) and
saphenous vein (SV) conduits in coro-
nary artery bypass grafting has several
methodologic flaws that significantly
limit its validity. Consequently, we
strongly believe that both the data pre-
sented and the conclusion that ‘‘no
definitive evidence supports the superi-
ority of the RA over the SV in terms of
graft failure rate’’1 cannot be accepted
without challenge.
Benedetto and colleagues’ restrictive
inclusion criteria1 may have excluded
data from several high-quality studies
that considered different target lesions
or used definitions of graft failure other
than total graft occlusion or severe dif-
fuse graft narrowing (string sign).1 An-
giographic stenosis of more than 50%,
70%, or 75%, for example, may cause
symptomatic ischemia and may require
repeated angiography. Finally, Bene-
detto and colleagues1 appear to have ex-
cluded important studies in which
assessment of angiographic patency
was performed at a fixed interval as a
secondary end point. These restrictive
inclusion criteria compromise they c Volume 139, Number 6 1669
